Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai Lopau

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 5, 2002
Progressive anorexia and chronic ascites after termination of CAPDKai Lopau, Christoph Wanner
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 2010
Hypertension after kidney transplantation: still a SECRET?Kai Lopau, Christoph Wanner
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 21, 2020
What Is the Utility of KDIGO Criteria to Identify High-Risk Populations?Christoph Wanner, Kai Lopau
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2020
The transition clinic in chronic kidney disease careMarie Evans, Kai Lopau
Der Internist|July 10, 2019
[Interstitial nephritis]Anna Laura Herzog, Kai Lopau
Clinical Transplantation|February 17, 2007
Efficacy and safety of preemptive anti-CMV therapy with valganciclovir after kidney transplantationKai Lopau, Alexandra Greser, Christoph Wanner
Kidney International|February 22, 2022
The safety and feasibility of incremental dialysis must be proven before its widespread useChristoph Wanner, Kai Lopau, Henrike Haberstroh
Deutsche Medizinische Wochenschrift (1946)|March 1, 2021
[Kidney as pacemaker for cardiovascular aging]Christoph Wanner, Jan Galle, Kai Lopau
Kidney & Blood Pressure Research|November 25, 2006
Effects of pravastatin treatment on blood pressure regulation after renal transplantationKai Lopau, Katrin Spindler, Christoph Wanner
Clinical Kidney Journal|April 17, 2020
Comparison of different algorithms for the assessment of cardiovascular risk after kidney transplantation by the time of entering waiting listAnna Laura Herzog, Charis Kalogirou, Christoph Wanner, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 5, 2002
Progressive anorexia and chronic ascites after termination of CAPDKai Lopau, Christoph Wanner
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 2010
Hypertension after kidney transplantation: still a SECRET?Kai Lopau, Christoph Wanner
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 21, 2020
What Is the Utility of KDIGO Criteria to Identify High-Risk Populations?Christoph Wanner, Kai Lopau
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2020
The transition clinic in chronic kidney disease careMarie Evans, Kai Lopau
Der Internist|July 10, 2019
[Interstitial nephritis]Anna Laura Herzog, Kai Lopau
Clinical Transplantation|February 17, 2007
Efficacy and safety of preemptive anti-CMV therapy with valganciclovir after kidney transplantationKai Lopau, Alexandra Greser, Christoph Wanner
Kidney International|February 22, 2022
The safety and feasibility of incremental dialysis must be proven before its widespread useChristoph Wanner, Kai Lopau, Henrike Haberstroh
Deutsche Medizinische Wochenschrift (1946)|March 1, 2021
[Kidney as pacemaker for cardiovascular aging]Christoph Wanner, Jan Galle, Kai Lopau
Kidney & Blood Pressure Research|November 25, 2006
Effects of pravastatin treatment on blood pressure regulation after renal transplantationKai Lopau, Katrin Spindler, Christoph Wanner
Clinical Kidney Journal|April 17, 2020
Comparison of different algorithms for the assessment of cardiovascular risk after kidney transplantation by the time of entering waiting listAnna Laura Herzog, Charis Kalogirou, Christoph Wanner, et al.
Pageof 4